Sanofi's diabetes division sales slow in Q2, Genzyme's jump
July 30, 2015 at 01:31 AM EDT
PARIS, July 30 (Reuters) - Sanofi's diabetes division reported lower sales in the second quarter, hurt by continued pricing pressure in the United States, but the French drugmaker's biotech arm Genzyme recorded another quarter with double-digit growth.
